CRF2 Signaling Is a Novel Regulator of Cellular Adhesion and Migration in Colorectal Cancer Cells

被引:19
作者
Ducarouge, Benjamin [1 ,2 ]
Pelissier-Rota, Marjolaine [1 ,2 ]
Laine, Michele [1 ,2 ]
Cristina, Nadine [1 ,2 ]
Vachez, Yvan [2 ]
Scoazec, Jean-Yves [3 ]
Bonaz, Bruno [1 ,2 ,4 ]
Jacquier-Sarlin, Muriel [1 ,2 ]
机构
[1] INSERM, U836, Equipe Stress & Interact Neurodigest, Grenoble, France
[2] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France
[3] Hop Edouard Herriot, Lyon, France
[4] Ctr Hosp Univ Grenoble, Grenoble, France
来源
PLOS ONE | 2013年 / 8卷 / 11期
关键词
CORTICOTROPIN-RELEASING HORMONE; E-CADHERIN EXPRESSION; ERK ACTIVATION; UROCORTIN; CATENIN; COLON; KAISO; PHOSPHORYLATION; P120(CTN); DISEASE;
D O I
10.1371/journal.pone.0079335
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Stress has been proposed to be a tumor promoting factor through the secretion of specific neuromediators, such as Urocortin2 and 3 (Ucn2/3), however its role in colorectal cancer (CRC) remains elusive. We observed that Ucn2/3 and their receptor the Corticotropin Releasing Factor receptor 2 (CRF2) were up-regulated in high grade and poorly differentiated CRC. This suggests a role for CRF2 in the loss of cellular organization and tumor progression. Using HT-29 and SW620 cells, two CRC cell lines differing in their abilities to perform cell-cell contacts, we found that CRF2 signals through Src/ERK pathway to induce the alteration of cell-cell junctions and the shuttle of p120ctn and Kaiso in the nucleus. In HT-29 cells, this signaling pathway also leads to the remodeling of cell adhesion by i) the phosphorylation of Focal Adhesion Kinase and ii) a modification of actin cytoskeleton and focal adhesion complexes. These events stimulate cell migration and invasion. In conclusion, our findings indicate that CRF2 signaling controls cellular organization and may promote metastatic potential of human CRC cells through an epithelial-mesenchymal transition like process. This contributes to the comprehension of the tumor-promoting effects of stress molecules and designates Ucn2/3-CRF2 tandem as a target to prevent CRC progression and aggressiveness.
引用
收藏
页数:14
相关论文
共 49 条
  • [1] Rho-kinase inhibitor upregulates migration by altering focal adhesion formation via the Akt pathway in colon cancer cells
    Adachi, Seiji
    Yasuda, Ichiro
    Nakashima, Masanori
    Yamauchi, Takahiro
    Yoshioka, Takashi
    Okano, Yukio
    Moriwaki, Hisataka
    Kozawa, Osamu
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 650 (01) : 145 - 150
  • [2] Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness
    Androulidaki, Ariadne
    Dermitzaki, Erini
    Venihaki, Maria
    Karagianni, Effie
    Rassouli, Olga
    Andreakou, Erini
    Stournaras, Christos
    Margioris, Andrew N.
    Tsatsanis, Christos
    [J]. MOLECULAR CANCER, 2009, 8
  • [3] Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma
    Arcuri, F
    Cintorino, M
    Florio, P
    Floccari, F
    Pergola, L
    Romagnoli, R
    Petraglia, F
    Tosi, P
    del Vecchio, MT
    [J]. PROSTATE, 2002, 52 (03) : 167 - 172
  • [4] Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease
    Bellovin, DI
    Bates, RC
    Muzikansky, A
    Rimm, DL
    Mercurio, AM
    [J]. CANCER RESEARCH, 2005, 65 (23) : 10938 - 10945
  • [5] Putting tumours in context
    Bissell, MJ
    Radisky, D
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 46 - 54
  • [6] Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells
    Chartier, NT
    Lainé, M
    Gout, S
    Pawlak, G
    Marie, CA
    Matos, P
    Block, MR
    Jacquier-Sarlin, MR
    [J]. JOURNAL OF CELL SCIENCE, 2006, 119 (01) : 31 - 46
  • [7] Chartier NT, 2011, EXP CELL RES
  • [8] CHEN FM, 1986, BRAIN RES, V381, P49
  • [9] Daniel JM, 1999, MOL CELL BIOL, V19, P3614
  • [10] Ducarouge B, 2012, TRENDS CELL MOL BIOL